MacroGenics Refocuses on Drug Discovery: $202.5 Million in Fresh Capital Fuels Pipeline and Extends Cash Runway Through 2028
Market Chameleon (Thu, 14-May 10:49 AM)
MGNX Secures $122.5 Million in Upfront Capital with Manufacturing Sale to Bora Pharmaceuticals
Market Chameleon (Tue, 12-May 10:33 AM)
